Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)
2 other identifiers
observational
5,000
1 country
2
Brief Summary
Background: \- The National Institute of Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, drug abuse and co-occurring psychiatric disorders, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen individuals who may be eligible for future research studies. Objectives: \- To identify, recruit, and screen participants for NIDA collaborative research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design:
- Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
- The in-person interview, which may require up to five visits to the clinical center, will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
- Participants will provide a photograph for confirmation of identity for subsequent visits and protocols.
- No clinical care will be provided under this protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2009
CompletedFirst Submitted
Initial submission to the registry
December 11, 2009
CompletedFirst Posted
Study publicly available on registry
December 14, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2012
CompletedJuly 2, 2017
April 10, 2012
December 11, 2009
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Adults (at least age 18)
- Ability to understand and answer the questions posed
You may not qualify if:
- \. Inability to provide valid informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National Institute on Drug Abuse, Biomedical Research Center (BRC)
Baltimore, Maryland, 21224, United States
Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue
Catonsville, Maryland, 21228, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David A Gorelick, M.D.
National Institute on Drug Abuse (NIDA)
Study Design
- Study Type
- observational
- Time Perspective
- OTHER
- Sponsor Type
- NIH
Study Record Dates
First Submitted
December 11, 2009
First Posted
December 14, 2009
Study Start
May 28, 2009
Study Completion
April 10, 2012
Last Updated
July 2, 2017
Record last verified: 2012-04-10